Evolent Health, Inc. EVH Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.89B+0.7% | $1.88B-8.7% | $2.05B-6.5% | $2.2B-8.5% | $2.4B-6.1% | ||
| $1.51B+2.1% | $1.48B-11.9% | $1.68B-8.8% | $1.84B-9.7% | $2.03B-7.1% | ||
| $381.19M-4.7% | $399.88M+5.7% | $378.34M+5.3% | $359.26M-1.8% | $365.72M-0.4% | ||
| 20.2%-1.1pp | 21.3%+2.9pp | 18.4%+2.1pp | 16.4%+1.1pp | 15.2%+0.9pp | ||
| $298.28M-1.8% | $303.87M+8.9% | $278.91M+3.9% | $268.38M+2.3% | $262.36M-0.3% | ||
| $113.35M-2.2% | $115.85M+15.7% | $100.11M-5.7% | $106.2M-6.0% | $112.93M-4.6% | ||
| $2.31B+0.9% | $2.29B+10.2% | $2.07B-7.1% | $2.23B-8.0% | $2.43B-6.5% | ||
| -$419.12M-2.2% | -$410.14M-1,900% | -$20.5M+45.6% | -$37.66M-31.2% | -$28.7M+29.1% | ||
| -22.2%-0.3pp | -21.9%-20.9pp | -1%+0.7pp | -1.7%-0.5pp | -1.2%+0.4pp | ||
| $63.95M+11.3% | $57.47M+27.2% | $45.18M+30.1% | $34.72M+19.3% | $29.11M+17.7% | ||
| $3.93M-6.2% | $4.19M+0.9% | $4.15M+4.3% | $3.98M-6.7% | $4.27M-23.0% | ||
| $1.04M+317% | $249K-34.1% | $378K+48.2% | $255K+37.8% | $185K-23.2% | ||
| $373K+2.2% | $365K+9.3% | $334K+116% | -$2.05M+48.0% | -$3.95M-9.0% | ||
| -$497.21M+7.0% | -$534.64M-318% | -$127.75M+2.9% | -$131.55M-20.2% | -$109.47M-73.7% | ||
| -$686K-444% | -$126K-129% | $430K+139% | -$1.1M-116% | -$508K+64.0% | ||
| -$496.52M+7.1% | -$534.51M-317% | -$128.18M+1.7% | -$130.45M-19.7% | -$108.96M-76.8% | ||
| -26.3%+2.2pp | -28.5%-22.2pp | -6.2%-0.3pp | -5.9%-1.4pp | -4.5%-2.1pp | ||
| $37.26M-17.0% | $44.89M-14.8% | $52.7M-3.7% | $54.73M+73.7% | $31.52M-1.0% | ||
| -$4.76+7.6% | -$5.15-226% | -$1.58+1.9% | -$1.61-30.9% | -$1.23-50.0% | ||
| -$4.76+7.6% | -$5.15-226% | -$1.58+1.9% | -$1.61-30.9% | -$1.23-50.0% | ||
| 456.1M-0.7% | 459.5M-0.1% | 459.9M-0.2% | 460.7M+0.3% | 459.5M+0.3% | ||
| 456.1M-0.7% | 459.5M-0.1% | 459.9M-0.2% | 460.7M+0.3% | 459.5M+0.3% | ||
| $6.78M+4.3% | $6.5M— | —— | —— | —— | ||
| -$535.68M+7.7% | -$580.27M-219% | -$181.89M+2.0% | -$185.54M-31.7% | -$140.9M-50.0% | ||
| -$196K+99.6% | -$52.54M0.0% | -$52.54M0.0% | -$52.54M-0.4% | -$52.35M— | ||
| —— | $14.87M+33.3% | $11.15M+50.0% | $7.43M+100% | $3.72M— | ||
| $1.23M+282% | -$676K+96.6% | -$19.6M+5.9% | -$20.83M0.0% | -$20.83M-10.1% | ||
| $1.04M+317% | $249K-34.1% | $378K+48.2% | $255K+37.8% | $185K-23.2% | ||
| $37.26M-17.0% | $44.89M-14.8% | $52.7M-3.7% | $54.73M+73.7% | $31.52M-1.0% | ||
| $1.89B+0.7% | $1.88B-8.7% | $2.05B-6.5% | $2.2B-8.5% | $2.4B-6.1% | ||
| -$419.12M-2.2% | -$410.14M-1,900% | -$20.5M+45.6% | -$37.66M-31.2% | -$28.7M+29.1% | ||
| -$305.77M-3.9% | -$294.29M-470% | $79.61M+16.1% | $68.54M-18.6% | $84.23M+8.1% | ||
| -$305.77M-3.9% | -$294.29M-470% | $79.61M+16.1% | $68.54M-18.6% | $84.23M+8.1% | ||
| -16.2%-0.5pp | -15.7%-19.6pp | 3.9%+0.8pp | 3.1%-0.4pp | 3.5%+0.5pp | ||
| -$419.12M-2.2% | -$410.14M-1,900% | -$20.5M+45.6% | -$37.66M-31.2% | -$28.7M+29.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Evolent Health, Inc.'s revenue?
- Evolent Health, Inc. (EVH) generated $1.9B in revenue over the trailing twelve months, down 21.3% year over year.
- Is Evolent Health, Inc. profitable?
- Evolent Health, Inc. is not currently profitable: it reported a net loss of $496.5M over the trailing twelve months, a -26.3% net margin.
- What are Evolent Health, Inc.'s profit margins?
- Gross margin is 20.2% and operating margin is -22.2%, with a -26.3% net margin.
- What is Evolent Health, Inc.'s earnings per share?
- Evolent Health, Inc.'s diluted EPS over the trailing twelve months is $-4.76.
- Where does Evolent Health, Inc.'s income statement data come from?
- Every line is extracted from Evolent Health, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
